|
AgrylinDrug - Agrylin The trade name of the product as shown on the labeling.
Dosage -
CAPSULE; ORAL
Active Ingredient(s) -
Anagrelide Hydrochloride
Strength -
EQ 1MG BASE
Applicant -
SHIRE
New Drug Application (NDA) Number -
020333
Product Number -
002
Therapeutic Equivalence (TE) Code -
AB
Approval Date -
Mar 14, 1997
Reference Listed Drug (RLD) -
Yes
Type -
RX
Applicant Full Name -
Shire Development Inc
Agrylin
Agrylin Eq 1mg Base Capsule; Oral
Principen W/ Probenecid Eq 389mg Base;111mg Capsule; Oral Principen W/ Probenecid Eq 389mg Base;111mg Capsule; Oral Polycillin-prb Eq 3.5gm Base/bot;1gm/bot For Suspension; Oral Polycillin-prb Eq 3.5gm Base/bot;1gm/bot For Suspension; Oral Probampacin Eq 3.5gm Base/bot;1gm/bot For Suspension; Oral Agenerase 150mg Capsule; Oral Agenerase 50mg Capsule; Oral Agenerase 15mg/ml Solution; Oral Agrylin Eq 0.5mg Base Capsule; Oral NewDrugInformation |